This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by O'Brien, T. D. Articles by Eberhardt, N. L. Search for Related Content PubMed PubMed Citation Articles by O'Brien, T. D. Articles by Eberhardt, N. L.

American Journal of Pathology, Vol 147, 609-616, Copyright © 1995 by American Society for Investigative Pathology

REGULAR ARTICLES

Human islet amyloid polypeptide expression in COS-1 cells. A model of intracellular amyloidogenesis

TD O'Brien, PC Butler, DK Kreutter, LA Kane and NL Eberhardt
Department of Veterinary PathoBiology, University of Minnesota, St. Paul, USA.

Non-insulin-dependent diabetes mellitus is characterized by concurrent loss of beta-cells and deposition of islet amyloid derived from islet amyloid polypeptide (IAPP). We have previously demonstrated that IAPP- derived amyloid forms intracellularly in humans with chronic excess insulin expression (eg, insulinoma and insulin receptor antibody- induced insulin resistance). To determine whether overexpression of IAPP results in intracellular amyloid in mammalian cells, we transfected COS cells with vectors expressing amyloidogenic human IAPP or non-amyloidogenic rat IAPP. Transfected COS-1 cells secreted comparable amounts of human IAPP and rat IAPP (2.1 to 2.8 nmol/L/48 hours). After 96 hours, 90% of cells expressing human IAPP contained amyloid fibrils and were degenerating or dead, whereas cells transfected with rat IAPP lacked amyloid and were viable. Thus, overexpression of human IAPP can result in intracellular amyloid formation that is associated with cell death, suggesting that intracellular amyloid may play a role in beta-cell loss in non-insulin- dependent diabetes mellitus.

This article has been cited by other articles:

				M. Apostolidou, S. A. Jayasinghe, and R. Langen Structure of {alpha}-Helical Membrane-bound Human Islet Amyloid Polypeptide and Its Implications for Membrane-mediated Misfolding J. Biol. Chem., June 20, 2008; 283(25): 17205 - 17210. [Abstract] [Full Text] [PDF]

				M. F. M. Engel, L. Khemtemourian, C. C. Kleijer, H. J. D. Meeldijk, J. Jacobs, A. J. Verkleij, B. de Kruijff, J. A. Killian, and J. W. M. Hoppener Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane PNAS, April 22, 2008; 105(16): 6033 - 6038. [Abstract] [Full Text] [PDF]

				J. J. Meier, R. Kayed, C.-Y. Lin, T. Gurlo, L. Haataja, S. Jayasinghe, R. Langen, C. G. Glabe, and P. C. Butler Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1317 - E1324. [Abstract] [Full Text] [PDF]

				J. F. Paulsson and G. T. Westermark Aberrant Processing of Human Proislet Amyloid Polypeptide Results in Increased Amyloid Formation Diabetes, July 1, 2005; 54(7): 2117 - 2125. [Abstract] [Full Text] [PDF]

				S. A. Jayasinghe and R. Langen Identifying Structural Features of Fibrillar Islet Amyloid Polypeptide Using Site-directed Spin Labeling J. Biol. Chem., November 12, 2004; 279(46): 48420 - 48425. [Abstract] [Full Text] [PDF]

				J. S. Rand, L. M. Fleeman, H. A. Farrow, D. J. Appleton, and R. Lederer Canine and Feline Diabetes Mellitus: Nature or Nurture? J. Nutr., August 1, 2004; 134(8): 2072S - 2080S. [Abstract] [Full Text] [PDF]

				J. Janson, T. Laedtke, J. E. Parisi, P. O'Brien, R. C. Petersen, and P. C. Butler Increased Risk of Type 2 Diabetes in Alzheimer Disease Diabetes, February 1, 2004; 53(2): 474 - 481. [Abstract] [Full Text]

				R. A. Ritzel and P. C. Butler Replication Increases {beta}-Cell Vulnerability to Human Islet Amyloid Polypeptide-Induced Apoptosis Diabetes, July 1, 2003; 52(7): 1701 - 1708. [Abstract] [Full Text] [PDF]

				S. Sakagashira, H. J. Hiddinga, K. Tateishi, T. Sanke, T. Hanabusa, K. Nanjo, and N. L. Eberhardt S20G Mutant Amylin Exhibits Increased in Vitro Amyloidogenicity and Increased Intracellular Cytotoxicity Compared to Wild-Type Amylin Am. J. Pathol., December 1, 2000; 157(6): 2101 - 2109. [Abstract] [Full Text] [PDF]

				M. Hoenig, G. Hall, D. Ferguson, K. Jordan, M. Henson, K. Johnson, and T. O'Brien A Feline Model of Experimentally Induced Islet Amyloidosis Am. J. Pathol., December 1, 2000; 157(6): 2143 - 2150. [Abstract] [Full Text] [PDF]

				H. J. Hiddinga and N. L. Eberhardt Intracellular Amyloidogenesis by Human Islet Amyloid Polypeptide Induces Apoptosis in COS-1 Cells Am. J. Pathol., April 1, 1999; 154(4): 1077 - 1088. [Abstract] [Full Text] [PDF]

				P. J. Tienari, N. Ida, E. Ikonen, M. Simons, A. Weidemann, G. Multhaup, C. L. Masters, C. G. Dotti, and K. Beyreuther Intracellular and secreted Alzheimer beta -amyloid species are generated by distinct mechanisms in cultured hippocampal neurons PNAS, April 15, 1997; 94(8): 4125 - 4130. [Abstract] [Full Text] [PDF]